Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mojoon vs WeightCare

Mojoon
Graded #515

Higher grade

vs+0.7
WeightCare
Graded #524

Lower grade

The verdict

Mojoon takes it — 52.9/100 to 52.2/100, but only just.

Mojoon grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Premium-priced telehealth provider offering compounded semaglutide. WeightCare is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWeightCare +5
30
35
Dose & formulationWeightCare +10
52
62
Clinical oversightMojoon +19
74
55
Labs & monitoringWeightCare +1
53
54
FulfillmentWeightCare +7
65
72
Contract termsMojoon +14
55
41
Mojoon · left barWeightCare · right bar

The numbers

MetricMojoonWeightCare
WeighScore52.9/10052.2/100
GradeCC
Scorecard rank#515#524
Semaglutide$450/mo (starting dose, compounded)$399/mo
TirzepatideNot disclosed$499/mo (15 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mojoon

Graded #515 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Premium pricing relative to market
WeightCare

Graded #524 · C

FDAWarning letter issued to Weightless Medical LLC dba WeightCare in February 2026. See the FDA warning-letter database.

Strengths

  • PCAB-accredited pharmacy partners — strongest pharmacy quality signal
  • Quality testing: potency and sterility per USP 797 standards
  • 85,000+ members since 2022 — established patient base
  • Multiple program tiers for semaglutide
  • Health coaching, dietitians, fitness trainers included

Where it loses points

  • No LegitScript certification on the site itself
  • State availability not explicitly listed
  • Compounded only — no brand-name options
  • Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose
  • FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard